ZA200007751B - Transdermal therapeutic system containing hormones and chrystallization inhibitors. - Google Patents

Transdermal therapeutic system containing hormones and chrystallization inhibitors.

Info

Publication number
ZA200007751B
ZA200007751B ZA200007751A ZA200007751A ZA200007751B ZA 200007751 B ZA200007751 B ZA 200007751B ZA 200007751 A ZA200007751 A ZA 200007751A ZA 200007751 A ZA200007751 A ZA 200007751A ZA 200007751 B ZA200007751 B ZA 200007751B
Authority
ZA
South Africa
Prior art keywords
chrystallization
inhibitors
system containing
therapeutic system
transdermal therapeutic
Prior art date
Application number
ZA200007751A
Other languages
English (en)
Inventor
Klein Robert Peter
Reinhold Meconi
Walter Mueller
Original Assignee
Lts Lohman Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohman Therapie Systeme Ag filed Critical Lts Lohman Therapie Systeme Ag
Publication of ZA200007751B publication Critical patent/ZA200007751B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/932—Specified use of nanostructure for electronic or optoelectronic application
    • Y10S977/939—Electron emitter, e.g. spindt emitter tip coated with nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200007751A 1998-06-25 2000-12-21 Transdermal therapeutic system containing hormones and chrystallization inhibitors. ZA200007751B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19828273A DE19828273B4 (de) 1998-06-25 1998-06-25 Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren

Publications (1)

Publication Number Publication Date
ZA200007751B true ZA200007751B (en) 2001-07-18

Family

ID=7871950

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200007751A ZA200007751B (en) 1998-06-25 2000-12-21 Transdermal therapeutic system containing hormones and chrystallization inhibitors.

Country Status (23)

Country Link
US (1) US6899894B1 (pl)
EP (1) EP1089719B1 (pl)
JP (1) JP2002518430A (pl)
KR (1) KR100550888B1 (pl)
CN (1) CN1148172C (pl)
AR (1) AR019715A1 (pl)
AT (1) ATE215819T1 (pl)
AU (1) AU768755B2 (pl)
BR (1) BR9912210A (pl)
CA (1) CA2335582C (pl)
CZ (1) CZ300707B6 (pl)
DE (2) DE19828273B4 (pl)
DK (1) DK1089719T3 (pl)
ES (1) ES2177290T3 (pl)
HU (1) HUP0102498A3 (pl)
IL (2) IL140434A0 (pl)
NZ (1) NZ509015A (pl)
PL (1) PL193080B1 (pl)
PT (1) PT1089719E (pl)
TR (1) TR200003839T2 (pl)
TW (1) TW533084B (pl)
WO (1) WO1999066901A2 (pl)
ZA (1) ZA200007751B (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10025971B4 (de) * 2000-05-25 2004-09-02 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System in Plasterform mit verminderter Tendenz zur Wirkstoffkristallisation und seine Verwendung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US6750291B2 (en) * 2002-04-12 2004-06-15 Pacific Corporation Film-forming agent for drug delivery and preparation for percutaneous administration containing the same
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
US20040086551A1 (en) * 2002-10-30 2004-05-06 Miller Kenneth J. Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
ATE295726T1 (de) * 2002-12-02 2005-06-15 Sanol Arznei Schwarz Gmbh Verabreichung von rotigotine zur behandlung der parkinson'schen krankheit durch iontophorese
DE10261696A1 (de) * 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
US20080286348A1 (en) * 2007-05-16 2008-11-20 Todhunter John A Secured transdermal delivery system
US20110028880A1 (en) * 2008-02-27 2011-02-03 Hisamitsu Pharmaceutical Co., Inc. Patch
EP2255802B1 (en) * 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
WO2009139411A1 (ja) 2008-05-15 2009-11-19 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
US8366600B2 (en) * 2008-06-19 2013-02-05 Nupathe Inc. Polyamine enhanced formulations for triptan compound iontophoresis
CN103933018A (zh) * 2013-01-18 2014-07-23 江苏康倍得药业有限公司 一种透皮给药系统
EP3395336A1 (en) * 2017-04-28 2018-10-31 Nitto Denko Corporation Transdermal absorption preparation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0745400B2 (ja) * 1986-03-29 1995-05-17 日東電工株式会社 外用医薬製剤
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
DE3743946A1 (de) 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JP2857882B2 (ja) * 1988-11-02 1999-02-17 富山化学工業株式会社 ピロキシカムのプラスター剤
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
DE3939376C1 (pl) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
GB9021674D0 (en) * 1990-10-05 1990-11-21 Ethical Pharma Ltd Transdermal device
JPH04261119A (ja) * 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤
CA2077369A1 (en) 1991-09-09 1993-03-10 Hitoshi Akemi Acrylic gel material and gel-based medical preparation for percutaneous absorption employing the same
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
US5286810A (en) * 1992-08-07 1994-02-15 Srchem Incorporated Salt of polymer from maleic acid, polyamind and ammonia
DE4230588C1 (de) * 1992-09-12 1993-10-07 Lohmann Therapie Syst Lts Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
HU223045B1 (hu) * 1993-04-20 2004-03-01 Hexal Ag. Ösztrogén vagy progesztagén hormont tartalmazó tapasz
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
EP0758229A1 (en) 1994-05-05 1997-02-19 Merck Frosst Canada Inc. Topical polymeric drug delivery system
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DE19548332A1 (de) * 1995-12-22 1997-07-10 Rotta Res Bv Hormonpflaster
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
US5951999A (en) * 1997-02-21 1999-09-14 Adhesives Research, Inc. Transdermal pressure sensitive adhesive drug delivery system
DE19728517C2 (de) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
CN1310616A (zh) 2001-08-29
US6899894B1 (en) 2005-05-31
CN1148172C (zh) 2004-05-05
CA2335582A1 (en) 1999-12-29
JP2002518430A (ja) 2002-06-25
CZ300707B6 (cs) 2009-07-22
NZ509015A (en) 2004-01-30
AU768755B2 (en) 2004-01-08
WO1999066901A3 (de) 2000-03-23
ATE215819T1 (de) 2002-04-15
CZ20004798A3 (en) 2001-05-16
DE19828273A1 (de) 1999-12-30
DK1089719T3 (da) 2002-08-05
IL140434A0 (en) 2002-02-10
PT1089719E (pt) 2002-09-30
DE19828273B4 (de) 2005-02-24
DE59901202D1 (de) 2002-05-16
KR100550888B1 (ko) 2006-02-10
EP1089719A2 (de) 2001-04-11
IL140434A (en) 2006-10-05
HUP0102498A3 (en) 2002-01-28
TW533084B (en) 2003-05-21
EP1089719B1 (de) 2002-04-10
TR200003839T2 (tr) 2001-06-21
PL193080B1 (pl) 2007-01-31
PL345455A1 (en) 2001-12-17
WO1999066901A2 (de) 1999-12-29
KR20010053132A (ko) 2001-06-25
AU4508699A (en) 2000-01-10
CA2335582C (en) 2006-04-11
ES2177290T3 (es) 2002-12-01
HUP0102498A2 (hu) 2001-11-28
BR9912210A (pt) 2001-04-10
AR019715A1 (es) 2002-03-13

Similar Documents

Publication Publication Date Title
ZA200007751B (en) Transdermal therapeutic system containing hormones and chrystallization inhibitors.
IL120943A0 (en) Transdermal delivery system
EP1073490A4 (en) DEVICE FOR DISCHARGING A MEDICINE AND RELATED METHODS
GB9918348D0 (en) Location finding system and method
ZA98376B (en) Sulfamide-metalloprotease inhibitors
HUP0002162A3 (en) Dose setting device
GB9707421D0 (en) Fracture reduction device
HK1048173A1 (zh) 尋找價值和減小風險的方法和系統
GB2321641B (en) Sulfamide-metalloprotease inhibitors
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
AU7472798A (en) Cox-2 inhibitors in combination with nmda-blockers for treating pain
EP1224577A4 (en) SYSTEM AND METHOD FOR ENABLING A USER TO NAVIGATE
ZA200203525B (en) Transdermal contraceptive delivery system and process.
HK1043791A1 (en) Imidazole compounds and medicinal use thereof.
IL211081A0 (en) Methods and devices for providing prolonged drug therapy
EP0977401A4 (en) ELECTRONIC DEVICE, METHOD FOR USE OF THE DEVICE AND SYSTEM WITH THE DEVICE
GB9809448D0 (en) Treatment device and method
HUP9802299A3 (en) Transdermal device for the delivery of alfuzosin
IL134491A0 (en) Dosage device
EP0987942A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD OF USE
EP1112250A4 (en) THERAPEUTIC COMPOUNDS AND RELATED METHODS
IL132605A0 (en) Softwall mining method and device
AU7792898A (en) Extraction agents and method for use thereof
GB9803032D0 (en) Transdermal delivery devices
GB9724817D0 (en) Transdermal dosage form